Bronchopericardial fistula, an unusual complication of oxytetracycline sclerosis therapy.

Interact Cardiovasc Thorac Surg

Department of Cardiovascular Surgery, Gazi University Hospital, Besevler, Ankara, Turkey.

Published: April 2008

Here we report a rare case of bronchopericardial fistula following intrapericardial instillation of oxytetracycline. A 63-year-old female patient was admitted for management of malignant pericardial effusion secondary to right-sided bronchogenic carcinoma. Medical therapy and recurrent percutaneous catheter drainage failed in resolving the problem, so subxiphoid pericardiostomy and drainage tube insertion was performed. There was no decrease in the drainage so we decided to perform pericardial sclerosis by intrapericardial tetracycline instillation. After the second time oxytetracycline instillation, the patient developed respiratory arrest with hemodynamic instability. A huge amount of yellow frothy secretion aspirated through the endotracheal tube. The presence of tetracycline in the bronchial secretion was proved by microbiological methods. The hemodynamic status of the patient deteriorated rapidly and despite all resuscitation measures we lost the patient within a few hours.

Download full-text PDF

Source
http://dx.doi.org/10.1510/icvts.2007.170290DOI Listing

Publication Analysis

Top Keywords

bronchopericardial fistula
8
fistula unusual
4
unusual complication
4
complication oxytetracycline
4
oxytetracycline sclerosis
4
sclerosis therapy
4
therapy report
4
report rare
4
rare case
4
case bronchopericardial
4

Similar Publications

Article Synopsis
  • - Pneumopericardium can occur as a rare complication of bronchopericardial fistula due to necrotizing pneumonia, which can lead to serious conditions like tension pneumopericardium requiring urgent medical intervention.
  • - A 41-year-old male with chronic conditions presented with respiratory symptoms and was diagnosed with necrotizing pneumonia that communicated with the pericardial cavity, showing air and fluid accumulation around the heart.
  • - The patient was treated with antibiotics and showed improvement, indicating that mild pneumopericardium can be managed conservatively, while early detection is essential to prevent complications and stabilize patient health.
View Article and Find Full Text PDF

Bronchial Fistula: Rare Complication of Treatment with Anlotinib.

Zhongguo Fei Ai Za Zhi

October 2020

Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha 410008, China.

Background: Anlotinib is a newly developed small molecule multiple receptor tyrosine kinase (RTK) inhibitor that was approved for the treatment of patients with lung cancer in China. We aim to report 3 cases of rare complication of anlotinib-bronchial fistula (BF) during the treatment of lung cancer patients and summarize the possible causes.

Methods: We collected three patients who developed BF due to anlotinib treatment, and conducted a search of Medline and PubMed for medical literature published between 2018 and 2020 using the following search terms: "anlotinib," "lung cancer," and "fistula.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!